Ulcerative Colitis?
New study treatments that may put you back in control.
The chronic inflammatory condition that causes inflammation and sores in the digestive tract has several options on the market. But, we’re working on giving you new options. Learn about the cutting-edge study treatments being investigated in your neighborhood.
48%
of people with Ulcerative Colitis are in remission.
2.1 million
prescriptions were written for Ulcerative Colitis in 2004.
34.9
years old is the median age of people diagnosed with Ulcerative Colitis.
I'm interested in different treatments. It would be nice to take something consistently to work on the condition itself. My meds don't prevent UC, they just minimize the symptoms I deal with. New treatments would give me more peace of mind.
Patient
3 years with Ulcerative Colitis
I'm interested in different treatments. It would be nice to take something consistently to work on the condition itself. My meds don't prevent UC, they just minimize the symptoms I deal with. New treatments would give me more peace of mind.
Patient
3 years with Ulcerative Colitis
Ulcerative Colitis Clinical Trials
Learn about the newest Ulcerative Colitis study treatments now being investigated, including cutting-edge options available to clinical trial participants.
TrialSpark is now recruiting for a trial that tests the effectiveness of a new study treatment for Ulcerative Colitis.
Ulcerative Colitis In the News
From the latest relevant research and Ulcerative Colitis expert interviews to personal stories and advice on managing your symptoms, here’s everything about UC that’s making headlines.
What to Know About Ulcerative Colitis and Pregnancy?
You may have concerns about becoming pregnant with Ulcerative Colitis, however the condition does not necessarily affect the chances of becoming pregnant, and women with ulcerative colitis can have a healthy pregnancy and a safe delivery. Here is everything you need to know...
Two Pharmaceutical Companies Partner to Create Oral Treatment for IBD
Innovation Pharmaceuticals (OTCQB:IPIX), a clinical stage biopharmaceutical company, has signed an agreement with BDD Pharma, an award-winning drug delivery company specializing in modified and controlled release oral formulations, to immediately begin the development of tablets for targeted oral delivery of Brilacidin to the colon.
Higher Health Costs for IBD Patients
A recent study suggests people with inflammatory bowel disease – either Crohn’s disease or ulcerative colitis – may incur health costs more than three times higher than individuals without these conditions.
How Your Fitbit Can Help Identify Upcoming Flare Ups
According to a new preliminary study out of the University of Chicago, data collected from activity trackers like Fitbits may serve as an early warning system for the estimated 3 million people with inflammatory bowel disease (IBD) in the U.S.
FAQ
Whether you’re considering participating in a clinical trial or just looking for more information about Ulcerative Colitis, we want you to keep you informed about living with UC, your treatment options, and the clinical trial process.
Living with Ulcerative Colitis
See allTreating Ulcerative Colitis
Join an Ulcerative Colitis Community
Connect with others who have Ulcerative Colitis to discuss your symptoms, experiences, treatment options, and more.
Stay updated on Ulcerative Colitis
We'll keep you updated on new and emerging treatments.
See if you qualify for a trial
New study treatments are being developed and investigated that may help address your condition.
Updated June 2019